Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Newron, Merck Serono conclude patient recruitment in Phase III MOTION study
Pharmaceutical Business Review
Wednesday, June 29, 2011 - 7:30am
tags:
Newron Pharma, Merck Serono, Parkinson's Disease
Medivir: terms of herpes-drug venture are reset
Marketwatch
Wednesday, June 29, 2011 - 6:57am
tags:
herpes, Medivir, Xerese, Meda
Are Dendreon Executives Properly Incentivized?
Seeking Alpha
Wednesday, June 29, 2011 - 6:55am
tags:
Dendreon, executive pay
Merck Says Submits Application for MS Treatment Rebif in Europe
Bloomberg
Wednesday, June 29, 2011 - 6:54am
tags:
Merck, Rebif, MS, Europe, multiple sclerosis
Acorda Pushes Sales of MS Drug
Minyanville
Wednesday, June 29, 2011 - 12:07am
tags:
Acorda Therapeutics, MS, multiple sclerosis, AMPYRA
Biogen Idec Has It All Among Biotech Firms
Seeking Alpha
Wednesday, June 29, 2011 - 12:06am
tags:
Biogen Idec
Study points to possible aspirin link with Astra heart drug
Reuters
Tuesday, June 28, 2011 - 11:38pm
tags:
AstraZeneca, Brilinta, aspirin
Hi-Tech Pharmacal: Bright Future in Generic Drugs
Seeking Alpha
Tuesday, June 28, 2011 - 11:36pm
tags:
Hi Tech Pharmacal, generics
New Data on Abbott Kidney Drug Candidate
Yahoo/Zacks.com
Tuesday, June 28, 2011 - 11:35pm
tags:
Abbott Laboratories, Shire, Sanofi, bardoxolone methyl, Reata, kidney disease
Where Is Teva Pharmaceutical Finding Growth?
Motley Fool
Tuesday, June 28, 2011 - 11:33pm
tags:
Teva Pharmaceuticals
J&J Recalling 60,000 Bottles of Tylenol, Citing Musty Odor
Bloomberg
Tuesday, June 28, 2011 - 11:32pm
tags:
recalls, JNJ, Tylenol
Amgen Seeks Label Expansion
Yahoo/Zacks.com
Tuesday, June 28, 2011 - 11:30pm
tags:
Amgen, GSK, Xgeva, prostate cancer
Gilead, Tibotec to work on new HIV-fighting drug combos
Bizjournals.com
Tuesday, June 28, 2011 - 11:29pm
tags:
Tibotec, Gilead Sciences, HIV, Prezista, Emtriva
Bristol-Myers signs deal to expand HIV drug access
Yahoo/AP
Tuesday, June 28, 2011 - 11:28pm
tags:
HIV, Bristol-Myers Squibb, Reyataz, generics, Matrixx
In Marketing Overhaul, J&J Aims for Integration
Motley Fool
Tuesday, June 28, 2011 - 11:26pm
tags:
marketing, JNJ, reorganization
Good news, bad news from diabetes gathering
Fierce Pharma
Tuesday, June 28, 2011 - 9:26am
tags:
diabetes, Takeda, GSK, Merck, Eli Lilly
Thanks To Icahn, Forest Labs Is Takeover Bait
Pharmalot
Tuesday, June 28, 2011 - 9:24am
tags:
Carl Icahn, M&A, Forest Labs
Vertex Tops Merck in Early Hep C Drug Launch
TheStreet.com
Tuesday, June 28, 2011 - 9:22am
tags:
hepatitis C, Merck, Vertex Pharmaceuticals, Incivek, Victrelis
Eli Lilly Blends 2 Drugs Into 1 in Next Step Forward for Cancer
Bloomberg
Tuesday, June 28, 2011 - 9:21am
tags:
Eli Lilly, cancer
Supreme Court To Review Case On Generic Delays
Pharmalot
Tuesday, June 28, 2011 - 8:57am
tags:
generics, Supreme Court, Caraco, Novo Nordisk, patents, FDA

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.